Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has shared an announcement.
ResMed Inc. announced an increase in the number of CHESS Depositary Interests (CDIs) issued over quoted securities, with a net addition of 3,066,120 CDIs in September 2025. This change is attributed to net transfers between CDIs and common stock, as well as activities related to stock options and employee stock plans. The company also reported a decrease in the number of securities over which CDIs have not been issued, due to share repurchases and new share issues on the NYSE.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$47.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc. operates in the healthcare industry, specializing in the development and manufacturing of equipment related to sleep disorders, particularly Continuous Positive Airway Pressure (CPAP) devices. The company focuses on improving the quality of life for patients with sleep apnea and other respiratory conditions, positioning itself as a leader in the sleep and respiratory care market.
Average Trading Volume: 1,037,884
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$59.91B
For an in-depth examination of RMD stock, go to TipRanks’ Overview page.